tiprankstipranks
Trending News
More News >
Organto Foods Inc (TSE:OGO)
:OGO

Organto Foods (OGO) AI Stock Analysis

Compare
11 Followers

Top Page

TS

Organto Foods

(OGO)

Rating:63Neutral
Price Target:
C$0.50
▼(-5.66%Downside)
Organto Foods' overall stock score is primarily influenced by its strong technical analysis and positive corporate events, which indicate potential for growth. However, financial performance remains a significant risk factor with persistent challenges in profitability, cash flow, and leverage. Valuation is moderate, but the absence of a dividend yield is a drawback.

Organto Foods (OGO) vs. iShares MSCI Canada ETF (EWC)

Organto Foods Business Overview & Revenue Model

Company DescriptionOrganto Foods Inc. (OGO) is a provider of organic and value-added fruits and vegetables. The company focuses on the sourcing, processing, packaging, and distribution of fresh produce to meet the growing consumer demand for organic and sustainably produced foods. Organto operates in the agriculture sector, emphasizing high-quality, ethically sourced products to promote healthier lifestyles and environmentally friendly practices.
How the Company Makes MoneyOrganto Foods generates revenue primarily through the sale of its organic fruits and vegetables. The company sources produce from a network of global growers and employs a vertically integrated business model that includes the processing, packaging, and distribution of its products. Organto sells its products to a variety of customers, including retailers, wholesalers, and food service providers. Significant partnerships with growers, logistics companies, and retail chains enhance its supply chain efficiency and market reach, contributing to its earnings. Additionally, Organto may engage in strategic collaborations and acquisitions to expand its product offerings and geographic presence, further driving revenue growth.

Organto Foods Financial Statement Overview

Summary
Organto Foods is facing significant financial challenges. The income statement reflects negative margins and fluctuating revenue growth, indicating instability. The balance sheet shows financial strain with negative equity and high leverage, while cash flow analysis highlights liquidity issues.
Income Statement
40
Negative
Organto Foods shows a challenging financial performance with negative margins. The gross profit margin has turned negative, indicating cost pressures. The net profit margin is also negative, reflecting consistent losses. The revenue growth rate is volatile with fluctuations, showcasing instability in revenue generation. EBIT and EBITDA margins remain negative, highlighting operational inefficiencies.
Balance Sheet
25
Negative
The balance sheet reflects financial strain with a negative stockholders' equity, signifying more liabilities than assets. The debt-to-equity ratio is undefined due to negative equity, indicating high financial leverage. The ROE is negative due to net losses, and the equity ratio is negative, suggesting financial instability and high risk.
Cash Flow
35
Negative
Cash flow analysis reveals negative operating cash flow, indicating cash consumption in operations. Free cash flow is negative, showing insufficient cash generation to cover capital expenditures. The operating cash flow to net income ratio and free cash flow to net income ratio are not meaningful as both cash flows and net income are negative, underscoring cash flow challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue29.68M20.70M27.68M22.12M19.52M11.45M
Gross Profit1.23M-985.08K2.46M1.26M1.99M1.07M
EBITDA875.18K-1.85M-9.19M-9.25M-5.32M-6.55M
Net Income-709.76K-4.54M-13.43M-10.83M-6.34M-7.05M
Balance Sheet
Total Assets10.21M6.03M6.92M11.37M20.96M6.77M
Cash, Cash Equivalents and Short-Term Investments862.79K357.60K195.04K5.86M11.87M4.13M
Total Debt12.68M12.52M12.21M8.98M8.44M4.15M
Total Liabilities21.95M19.95M22.45M14.53M14.27M7.01M
Stockholders Equity-11.74M-13.91M-15.54M-3.16M6.69M-237.91K
Cash Flow
Free Cash Flow-4.02M-3.00M-3.91M-5.84M-5.92M-1.99M
Operating Cash Flow-4.02M-3.00M-3.89M-5.72M-5.92M-1.99M
Investing Cash Flow-40.46K-40.18K-318.38K-928.58K-357.41K0.00
Financing Cash Flow4.72M3.17M-1.39M-312.04K13.99M6.22M

Organto Foods Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.53
Price Trends
50DMA
0.37
Positive
100DMA
0.25
Positive
200DMA
0.16
Positive
Market Momentum
MACD
0.06
Positive
RSI
67.56
Neutral
STOCH
30.16
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:OGO, the sentiment is Positive. The current price of 0.53 is above the 20-day moving average (MA) of 0.47, above the 50-day MA of 0.37, and above the 200-day MA of 0.16, indicating a bullish trend. The MACD of 0.06 indicates Positive momentum. The RSI at 67.56 is Neutral, neither overbought nor oversold. The STOCH value of 30.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:OGO.

Organto Foods Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
TSOGO
63
Neutral
C$59.24M13.3257.30%10.57%
54
Neutral
C$4.43B4.00-20.57%3.83%8.18%1.50%
37
Underperform
C$9.40M162.13%-5.97%63.24%
TSZOG
30
Underperform
C$671.06K0.64-229.06%
27
Underperform
C$4.39M-78.70%-97.30%39.70%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:OGO
Organto Foods
0.53
0.47
783.33%
TSE:ZOG
Zoglo's Incredible Food Corp.
0.04
-0.08
-66.67%
TSE:NPRA
Nepra Foods
0.09
0.05
100.00%
TSE:PNGA
Pangea Natural Food, Inc.
0.29
-0.22
-43.14%

Organto Foods Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Organto Foods Secures C$1.0 Million Through Strategic Private Placement
Positive
Jun 26, 2025

Organto Foods Inc. has successfully closed a non-brokered private placement, raising C$1.0 million through the issuance of 4,000,000 units at a price of $0.25 per unit. This financing was completed with a strategic investor and will support the company’s general working capital. The transaction includes common shares and warrants, with a hold period until October 27, 2025. This move is expected to bolster Organto’s operational capabilities and enhance its market positioning in the organic produce industry.

Shareholder MeetingsBusiness Operations and Strategy
Organto Foods Reports Strong Shareholder Support at Annual Meeting
Positive
Jun 25, 2025

Organto Foods Inc. announced the results of its annual general meeting, where 57.9% of eligible shares were voted, and all matters received over 99% support. Shareholders elected five directors and approved the appointment of Dale Matheson Carr-Hilton Labonte LLP as the independent auditor for the next year. The continuation of the company’s Share Option and Restricted Share Unit Plans was also approved, indicating strong shareholder confidence in Organto’s strategic direction.

Private Placements and FinancingBusiness Operations and Strategy
Organto Foods Completes Convertible Debenture Settlement to Boost Equity
Positive
Jun 20, 2025

Organto Foods Inc. has announced the final settlement of its convertible debenture obligations, exchanging C$8,050,000 worth of debentures for 40,250,000 common shares. This move is part of Organto’s strategy to reduce debt and increase equity, positioning the company for future growth. The settlement reflects the company’s commitment to building a world-class foods company and creating long-term value for stakeholders. The company has also engaged Jaluca Limited to assist in its restructuring efforts, issuing additional shares as part of the advisory agreement.

Private Placements and FinancingBusiness Operations and Strategy
Organto Foods Secures C$1.0 Million Private Placement to Fuel Growth
Positive
Jun 18, 2025

Organto Foods Inc. announced a C$1.0 million private placement financing with a strategic investor, aiming to issue up to 4,000,000 units at $0.25 per unit. This move is part of Organto’s strategy to manage its balance sheet conservatively while capitalizing on its recent operational success, including significant sales and profit growth. The proceeds will be used for general working capital, and the transaction is subject to regulatory approvals. The announcement reflects the company’s ongoing restructuring efforts and strategic realignment, which have laid a foundation for sustained growth and profitability.

Business Operations and StrategyFinancial Disclosures
Organto Foods Reports Record Q1 2025 Financial Results
Positive
May 28, 2025

Organto Foods Inc. announced record-breaking financial results for the first quarter of 2025, with sales reaching $13.6 million, a 193.5% increase from the previous year. The company achieved its first positive EBITDA quarter, attributed to strategic restructuring and cost reduction efforts. This performance highlights Organto’s momentum towards sustained growth and profitability, as well as its commitment to creating lasting value for stakeholders.

Private Placements and FinancingBusiness Operations and Strategy
Organto Foods Secures Debentureholder Approval for Debt Settlement
Positive
May 1, 2025

Organto Foods Inc. announced that its debentureholders have approved the settlement terms for its 5-year, 8% convertible unsecured subordinated debentures. The resolution allows for the conversion of $8,050,000 worth of debentures into 40,250,000 common shares, effectively reducing the company’s debt and increasing equity. This move is part of Organto’s ongoing efforts to improve its financial structure and enhance its market position. The approval by debentureholders representing 68.89% of the outstanding principal amount eliminates the need for a formal meeting, although the settlement still requires approval from the TSX Venture Exchange.

Business Operations and StrategyFinancial Disclosures
Organto Foods Reports Strong Fiscal 2024 Results Amid Restructuring
Positive
Apr 28, 2025

Organto Foods Inc. reported its fiscal 2024 financial results, highlighting a significant restructuring and realignment that has positioned the company for sustained growth and profitability. The company achieved a 48% increase in sales to $20.7 million, driven by onboarding new business and expanding sales with existing customers. Despite a net loss from continuing operations of $3.3 million, Organto reduced its net loss including discontinued operations to $2.0 million, down from $13.4 million in 2023, aided by gains from the sale of subsidiaries and improved operating earnings. The company remains focused on positive cash flow and is optimistic about its future prospects.

Business Operations and Strategy
Organto Foods Strengthens Investor Relations with New Agreements and Stock Options
Positive
Apr 17, 2025

Organto Foods Inc. has announced new investor relations agreements and the issuance of stock options to its directors, officers, and employees. The company has engaged 12538938 Canada Inc. for strategic communication services and Atrium Research Corporation for issuer-paid research to enhance its investment case to potential investors. These initiatives aim to strengthen Organto’s market presence and investor engagement, potentially impacting its operational strategies and stakeholder relations.

Private Placements and FinancingBusiness Operations and Strategy
Organto Foods Completes Financing and Debt Restructuring
Positive
Apr 16, 2025

Organto Foods Inc. has successfully closed a private placement, raising C$5,309,991 through the issuance of common shares, and has settled outstanding debts amounting to C$2,243,300 via a shares-for-debt arrangement. Additionally, the company has amended the terms of its convertible notes, reducing the conversion and acceleration prices, and extending the maturity dates, which could enhance its financial flexibility and improve its market positioning.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 09, 2025